Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Does fibrosis really regress in HIV/HCV co-infected patients after treatment with direct-antiviral agents?

Rial-Crestelo D, Sepúlveda MA, González-Gasca FJ, Geijo-Martínez P, Martínez-Alfaro E, Barberá JR, Yzusqui M, Casallo S, García M, Hornero CM, Espinosa-Gimeno A, Torralba M.

AIDS. 2019 Nov 14. doi: 10.1097/QAD.0000000000002433. [Epub ahead of print]

PMID:
31764078
2.

Outcomes by sex following treatment initiation with darunavir/cobicistat in a large Spanish cohort of the CODAR study (GeSIDA 9316).

Pérez Elías MJ, Alejos B, Vivancos MJ, Ribera E, Galindo MJ, Vilanova-Trillo L, García-Fraile Fraile LJ, de La Fuente Moral S, Garcia De Lomas J, Lozano F, Mateo García MG, Tasias Pitarch M, Diez Martinez M, Rojas J, Raya-Cruz M, Sepúlveda MA, Troya J, Del Campo S, Martinez E.

J Antimicrob Chemother. 2019 Oct 1;74(10):3124. doi: 10.1093/jac/dkz331. No abstract available.

PMID:
31377772
3.

Outcomes by sex following treatment initiation with darunavir/cobicistat in a large Spanish cohort of the CODAR study (GeSIDA 9316).

Pérez Elías MJ, Alejos B, Vivancos MJ, Ribera E, Galindo MJ, Vilanova-Trillo L, García-Fraile Fraile LJ, de La Fuente Moral S, Garcia De Lomas J, Lozano F, Mateo García MG, Tasias Pitarch M, Diez Martinez M, Rojas J, Raya-Cruz M, Sepúlveda MA, Troya J, Del Campo S, Martinez E; CODAR study group .

J Antimicrob Chemother. 2019 Oct 1;74(10):3044-3048. doi: 10.1093/jac/dkz254.

PMID:
31236601
4.

Role of age and comorbidities in mortality of patients with infective endocarditis.

Armiñanzas C, Fariñas-Alvarez C, Zarauza J, Muñoz P, González Ramallo V, Martínez Sellés M, Miró Meda JM, Pericás JM, Goenaga MÁ, Ojeda Burgos G, Rodríguez Álvarez R, Castelo Corral L, Gálvez-Acebal J, Martínez Marcos FJ, Fariñas MC; Spanish Collaboration on Endocarditis — Grupo de Apoyo al Manejo de la Endocarditis Infecciosa en Espana Study Group, Fernández Sánchez F, Noureddine M, Rosas G, de la Torre Lima J, Aramendi J, Bereciartua E, Blanco MJ, Blanco R, Boado MV, Campaña Lázaro M, Crespo A, Goikoetxea J, Iruretagoyena JR, Irurzun Zuazabal J, López-Soria L, Montejo M, Nieto J, Rodrigo D, Rodríguez D, Rodríguez R, Vitoria Y, Voces R, García López MV, Georgieva RI, Ojeda G, Rodríguez Bailón I, Ruiz Morales J, Cuende AM, Echeverría T, Fuerte A, Gaminde E, Goenaga MÁ, Idígoras P, Iribarren JA, Izaguirre Yarza A, Kortajarena Urkola X, Reviejo C, Carrasco R, Climent V, Llamas P, Merino E, Plazas J, Reus S, Álvarez N, Bravo-Ferrer JM, Castelo L, Cuenca J, Llinares P, Miguez Rey E, Rodríguez Mayo M, Sánchez E, Sousa Regueiro D, Martínez FJ, Alonso MDM, Castro B, García Rosado D, Durán MDC, Miguel Gómez MA, Lacalzada J, Nassar I, Plata Ciezar A, Reguera Iglesias JM, Asensi Álvarez V, Costas C, de la Hera J, Fernández Suárez J, Iglesias Fraile L, León Arguero V, López Menéndez J, Mencia Bajo P, Morales C, Moreno Torrico A, Palomo C, Paya Martínez B, Rodríguez Esteban Á, Rodríguez García R, Telenti Asensio M, Almela M, Ambrosioni J, Azqueta M, Brunet M, Bodro M, Cartañá R, Falces C, Fita G, Fuster D, García de la Mària C, Hernández-Meneses M, Llopis Pérez J, Marco F, Miró JM, Moreno A, Nicolás D, Ninot S, Quintana E, Paré C, Pereda D, Pericás JM, Pomar JL, Ramírez J, Rovira I, Sandoval E, Sitges M, Soy D, Téllez A, Tolosana JM, Vidal B, Vila J, Adán I, Bermejo J, Bouza E, Celemín D, Cuerpo Caballero G, Delgado Montero A, Fernández Cruz A, García Mansilla A, García Leoni ME, González Ramallo V, Kestler Hernández M, Hualde AM, Marín M, Martínez-Sellés M, Menárguez MC, Muñoz P, Rincón C, Rodríguez-Abella H, Rodríguez-Créixems M, Pinilla B, Pinto Á, Valerio M, Vázquez P, Verde Moreno E, Antorrena I, Loeches B, Martín Quirós A, Moreno M, Ramírez U, Rial Bastón V, Romero M, Saldaña A, Agüero Balbín J, Amado C, Armiñanzas Castillo C, Arnaiz García A, Cobo Belaustegui M, Fariñas MC, Fariñas-Álvarez C, Gómez Izquierdo R, García I, González-Rico C, Gutiérrez-Cuadra M, Gutiérrez Díez J, Pajarón M, Parra JA, Sarralde A, Teira R, Zarauza J, Domínguez F, García Pavía P, González J, Orden B, Ramos A, Centella T, Hermida JM, Moya JL, Martín-Dávila P, Navas E, Oliva E, Del Río A, Ruiz S, Hidalgo Tenorio C, Almendro Delia M, Araji O, Barquero JM, Calvo Jambrina R, de Cueto M, Gálvez Acebal J, Méndez I, Morales I, López-Cortés LE, de Alarcón A, García E, Haro JL, Lepe JA, López F, Luque R, Alonso LJ, Azcárate P, Azcona Gutiérrez JM, Blanco JR, García-Álvarez L, Oteo JA, Sanz M, de Benito N, Gurguí M, Pacho C, Pericas R, Pons G, Álvarez M, Fernández AL, Martínez A, Prieto A, Regueiro B, Tijeira E, Vega M, Canut Blasco A, Cordo Mollar J, Gainzarain Arana JC, García Uriarte O, Martín López A, Ortiz de Zárate Z, Urturi Matos JA, García Domínguez G, Sánchez-Porto A, Arribas Leal JM, García Vázquez E, Hernández Torres A, Blázquez A, de la Morena Valenzuela G, Alonso Á, Aramburu J, Calvo FE, Moreno Rodríguez A, Tarabini-Castellani P, Heredero Gálvez E, Maicas Bellido C, Largo Pau J, Sepúlveda MA, Toledano Sierra P, Iqbal-Mirza SZ, Cascales Alcolea E, Egea Serrano P, Hernández Roca JJ, Keituqwa Yañez I, Peláez Ballesta A, Soriano V, Moreno Escobar E, Peña Monje A, Sánchez Cabrera V, Vinuesa García D, Arrizabalaga Asenjo M, Cifuentes Luna C, Núñez Morcillo J, Pérez Seco MC, Villoslada Gelabert A, Aured Guallar C, Fernández Abad N, García Mangas P, Matamala Adell M, Palacián Ruiz MP, Porres JC, Alcaraz Vidal B, Cobos Trigueros N, Del Amor Espín MJ, Giner Caro JA, Jiménez Sánchez R, Jimeno Almazán A, Ortín Freire A, Viqueira González M, Pericás Ramis P, Ribas Blanco MÁ, Ruiz de Gopegui Bordes E, Vidal Bonet L, Bellón Munera MC, Escribano Garaizabal E, Tercero Martínez A, Segura Luque JC.

Eur J Intern Med. 2019 Jun;64:63-71. doi: 10.1016/j.ejim.2019.03.006. Epub 2019 Mar 21.

PMID:
30904433
5.

When free-ranging dogs threaten wildlife: Public attitudes toward management strategies in southern Chile.

Villatoro FJ, Naughton-Treves L, Sepúlveda MA, Stowhas P, Mardones FO, Silva-Rodríguez EA.

J Environ Manage. 2019 Jan 1;229:67-75. doi: 10.1016/j.jenvman.2018.06.035. Epub 2018 Aug 22.

PMID:
30143314
6.

Efficacy and safety of sensor-augmented pump therapy (SAPT) with predictive low-glucose management in patients diagnosed with type 1 diabetes mellitus previously treated with SAPT and low glucose suspend.

Gómez AM, Henao DC, Imitola A, Muñoz OM, Sepúlveda MAR, Kattah L, Guerrero JS, Morros E, Llano JP, Jaramillo MG, León-Vargas F.

Endocrinol Diabetes Nutr. 2018 Oct;65(8):451-457. doi: 10.1016/j.endinu.2018.03.009. Epub 2018 Jun 18. English, Spanish.

PMID:
29914817
7.

Raltegravir plus abacavir/lamivudine in virologically suppressed HIV-1-infected patients: 48-week results of the KIRAL study.

Troya J, Montejano R, Ryan P, Gómez C, Matarranz M, Cabello A, Vera F, Sepúlveda MA, Santos I, Samperiz G, Bachiller P, Boix V, Barrufet P, Cervero M, Sanz J, Solís J, Yllescas M, Valencia E; GESIDA-8715 Study Group.

PLoS One. 2018 Jun 14;13(6):e0198768. doi: 10.1371/journal.pone.0198768. eCollection 2018.

8.

Lipid changes and tolerability in a cohort of adult HIV-infected patients who switched to rilpivirine/emtricitabine/tenofovir due to intolerance to previous combination ART: the PRO-STR study.

Ocampo A, Domingo P, Fernández P, Diz J, Barberá JR, Sepúlveda MA, Salgado X, Rodriguez M, Santos J, Yzusqui M, Mayorga MI, Lorenzo JF, Bahamonde A, Bachiller P, Martínez E, Rozas N, Torres C, Muñoz A, Casado A, Podzamczer D.

J Antimicrob Chemother. 2018 Aug 1;73(8):2171-2176. doi: 10.1093/jac/dky175.

PMID:
29788066
9.

Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of Tumors.

Kumar V, Donthireddy L, Marvel D, Condamine T, Wang F, Lavilla-Alonso S, Hashimoto A, Vonteddu P, Behera R, Goins MA, Mulligan C, Nam B, Hockstein N, Denstman F, Shakamuri S, Speicher DW, Weeraratna AT, Chao T, Vonderheide RH, Languino LR, Ordentlich P, Liu Q, Xu X, Lo A, Puré E, Zhang C, Loboda A, Sepulveda MA, Snyder LA, Gabrilovich DI.

Cancer Cell. 2017 Nov 13;32(5):654-668.e5. doi: 10.1016/j.ccell.2017.10.005.

10.

Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients.

Condamine T, Dominguez GA, Youn JI, Kossenkov AV, Mony S, Alicea-Torres K, Tcyganov E, Hashimoto A, Nefedova Y, Lin C, Partlova S, Garfall A, Vogl DT, Xu X, Knight SC, Malietzis G, Lee GH, Eruslanov E, Albelda SM, Wang X, Mehta JL, Bewtra M, Rustgi A, Hockstein N, Witt R, Masters G, Nam B, Smirnov D, Sepulveda MA, Gabrilovich DI.

Sci Immunol. 2016 Aug;1(2). pii: aaf8943. doi: 10.1126/sciimmunol.aaf8943. Epub 2016 Aug 5.

11.

VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer.

Gao J, Ward JF, Pettaway CA, Shi LZ, Subudhi SK, Vence LM, Zhao H, Chen J, Chen H, Efstathiou E, Troncoso P, Allison JP, Logothetis CJ, Wistuba II, Sepulveda MA, Sun J, Wargo J, Blando J, Sharma P.

Nat Med. 2017 May;23(5):551-555. doi: 10.1038/nm.4308. Epub 2017 Mar 27.

12.

Urban dogs in rural areas: Human-mediated movement defines dog populations in southern Chile.

Villatoro FJ, Sepúlveda MA, Stowhas P, Silva-Rodríguez EA.

Prev Vet Med. 2016 Dec 1;135:59-66. doi: 10.1016/j.prevetmed.2016.11.004. Epub 2016 Nov 9.

PMID:
27931930
13.

Prevalence of sleep complaints in Colombia at different altitudes.

Ruiz AJ, Sepúlveda MA, Martínez PH, Muñoz MC, Mendoza LO, Centanaro OP, Carrasco LF, García JC.

Sleep Sci. 2016 Apr-Jun;9(2):100-5. doi: 10.1016/j.slsci.2016.05.008. Epub 2016 Jun 4.

14.

The DNA methylation profile of activated human natural killer cells.

Wiencke JK, Butler R, Hsuang G, Eliot M, Kim S, Sepulveda MA, Siegel D, Houseman EA, Kelsey KT.

Epigenetics. 2016 May 3;11(5):363-80. doi: 10.1080/15592294.2016.1163454. Epub 2016 Mar 11.

15.

Impact of Cell-surface Antigen Expression on Target Engagement and Function of an Epidermal Growth Factor Receptor × c-MET Bispecific Antibody.

Jarantow SW, Bushey BS, Pardinas JR, Boakye K, Lacy ER, Sanders R, Sepulveda MA, Moores SL, Chiu ML.

J Biol Chem. 2015 Oct 9;290(41):24689-704. doi: 10.1074/jbc.M115.651653. Epub 2015 Aug 10.

16.

Postmortem findings in four south American sea lions (Otaria byronia) from an urban colony in Valdivia, Chile.

Sepúlveda MA, Seguel M, Alvarado-Rybak M, Verdugo C, Muñoz-Zanzi C, Tamayo R.

J Wildl Dis. 2015 Jan;51(1):279-82. doi: 10.7589/2013-07-161.

PMID:
25380367
17.

Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy.

Fan X, Quezada SA, Sepulveda MA, Sharma P, Allison JP.

J Exp Med. 2014 Apr 7;211(4):715-25. doi: 10.1084/jem.20130590. Epub 2014 Mar 31.

18.

Invasive American mink: linking pathogen risk between domestic and endangered carnivores.

Sepúlveda MA, Singer RS, Silva-Rodríguez EA, Eguren A, Stowhas P, Pelican K.

Ecohealth. 2014 Sep;11(3):409-19. doi: 10.1007/s10393-014-0917-z. Epub 2014 Mar 7.

PMID:
24604545
19.

Domestic dogs in rural communities around protected areas: conservation problem or conflict solution?

Sepúlveda MA, Singer RS, Silva-Rodríguez E, Stowhas P, Pelican K.

PLoS One. 2014 Jan 20;9(1):e86152. doi: 10.1371/journal.pone.0086152. eCollection 2014.

20.

Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma.

Simpson TR, Li F, Montalvo-Ortiz W, Sepulveda MA, Bergerhoff K, Arce F, Roddie C, Henry JY, Yagita H, Wolchok JD, Peggs KS, Ravetch JV, Allison JP, Quezada SA.

J Exp Med. 2013 Aug 26;210(9):1695-710. doi: 10.1084/jem.20130579. Epub 2013 Jul 29.

21.

Cutting edge: chronic inflammatory liver disease in mice expressing a CD28-specific ligand.

Corse E, Gottschalk RA, Park JS, Sepulveda MA, Loke P, Sullivan TJ, Johnson LK, Allison JP.

J Immunol. 2013 Jan 15;190(2):526-30. doi: 10.4049/jimmunol.1202621. Epub 2012 Dec 17.

22.

[Introduction to Exploratory Factor Analysis (EFA)].

Martínez CM, Sepúlveda MA.

Rev Colomb Psiquiatr. 2012 Mar;41(1):197-207. doi: 10.1016/S0034-7450(14)60077-9. Epub 2014 May 10. Spanish.

PMID:
26573478
23.

Toxoplasma gondii in feral American minks at the Maullín river, Chile.

Sepúlveda MA, Muñoz-Zanzi C, Rosenfeld C, Jara R, Pelican KM, Hill D.

Vet Parasitol. 2011 Jan 10;175(1-2):60-5. doi: 10.1016/j.vetpar.2010.09.020. Epub 2010 Sep 29.

PMID:
20965660
24.

Effect of simplification from protease inhibitors to boosted atazanavir-based regimens in real-life conditions.

Rubio R, Serrano O, Carmena J, Asensi V, Echevarría S, Flores J, Ribera E, Zarraga M, Ocampo A, de la Fuente B, Sepúlveda MA, Mariño AI, Minguez C, Vicent R, Cartón JA, Moyano B, Esteban H, Mahillo B, Serrano L, González-García J; GESIDA 44/04 SIMPATAZ Study Group.

HIV Med. 2010 Oct 1;11(9):545-53. doi: 10.1111/j.1468-1293.2010.00827.x. Epub 2010 Mar 19.

25.

Characteristics and outcome of AIDS-related Hodgkin lymphoma before and after the introduction of highly active antiretroviral therapy.

Berenguer J, Miralles P, Ribera JM, Rubio R, Valencia E, Mahillo B, Pintado V, Palacios R, Montes ML, Téllez MJ, La Cruz J, Torre-Cisneros J, Rodríguez-Arrondo F, Sepúlveda MA, Gutiérrez F, Peralta G, Boix V.

J Acquir Immune Defic Syndr. 2008 Apr 1;47(4):422-8.

PMID:
18434957
26.

[Molecular identification of aminoglycoside-modifying enzymes among strains of Enterococcus spp. isolated in hospitals of the VIII Region of Chile].

Sepúlveda MA, Bello HT, Domínguez MY, Mella SM, Zemelman RZ, González GR.

Rev Med Chil. 2007 May;135(5):566-72. Epub 2007 Jul 9. Spanish.

27.

Changes in replication, nuclear location, and expression of the Igh locus after fusion of a pre-B cell line with a T cell line.

Zhou J, Saleque S, Ermakova O, Sepulveda MA, Yang Q, Eckhardt LA, Schildkraut CL, Birshtein BK.

J Immunol. 2005 Aug 15;175(4):2317-20.

28.

Chromatin architecture near a potential 3' end of the igh locus involves modular regulation of histone modifications during B-Cell development and in vivo occupancy at CTCF sites.

Garrett FE, Emelyanov AV, Sepulveda MA, Flanagan P, Volpi S, Li F, Loukinov D, Eckhardt LA, Lobanenkov VV, Birshtein BK.

Mol Cell Biol. 2005 Feb;25(4):1511-25.

29.

Comparative analysis of human and mouse 3' Igh regulatory regions identifies distinctive structural features.

Sepulveda MA, Garrett FE, Price-Whelan A, Birshtein BK.

Mol Immunol. 2005 Mar;42(5):605-15.

PMID:
15607820
30.

NF-kappa B and Oct-2 synergize to activate the human 3' Igh hs4 enhancer in B cells.

Sepulveda MA, Emelyanov AV, Birshtein BK.

J Immunol. 2004 Jan 15;172(2):1054-64.

31.

A novel human Ada2 homologue functions with Gcn5 or Brg1 to coactivate transcription.

Barlev NA, Emelyanov AV, Castagnino P, Zegerman P, Bannister AJ, Sepulveda MA, Robert F, Tora L, Kouzarides T, Birshtein BK, Berger SL.

Mol Cell Biol. 2003 Oct;23(19):6944-57.

32.

The interaction of Pax5 (BSAP) with Daxx can result in transcriptional activation in B cells.

Emelyanov AV, Kovac CR, Sepulveda MA, Birshtein BK.

J Biol Chem. 2002 Mar 29;277(13):11156-64. Epub 2002 Jan 17.

33.

[Evaluation of 2 tuberculosis chemoprophylaxis regimens in patients infected with human immunodeficiency virus. The GECMEI Group].

Martínez Alfaro EM, Cuadra F, Solera J, Maciá MA, Geijo P, Sánchez Martínez PA, Rodríguez Zapata M, Largo J, Sepúlveda MA, Rosa C, Sánchez L, Espinosa A, Mateos F, Blanch JJ.

Med Clin (Barc). 2000 Jul 1;115(5):161-5. Spanish.

PMID:
10996870
34.

[Prevalence of IgG antibodies against Cytomegalovirus in patients with angiographically demonstrated coronary atherosclerosis].

Sepúlveda MA, Moreu J, Cantón T, Pajin F, Rodríguez L.

Enferm Infecc Microbiol Clin. 1999 Oct;17(8):386-9. Spanish.

PMID:
10563085
35.

[Laryngeal leishmaniasis in an immunocompetent patient].

Sepúlveda MA, Julián A, García García JF.

Enferm Infecc Microbiol Clin. 1998 Aug-Sep;16(7):344. Spanish. No abstract available.

PMID:
9808888
36.

Treatment of human brucellosis with netilmicin and doxycycline.

Solera J, Espinosa A, Geijo P, Martínez-Alfaro E, Sáez L, Sepúlveda MA, Ruiz-Ribó MD.

Clin Infect Dis. 1996 Mar;22(3):441-5.

PMID:
8852960
37.

Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI Group. Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas.

Solera J, Rodríguez-Zapata M, Geijo P, Largo J, Paulino J, Sáez L, Martínez-Alfaro E, Sánchez L, Sepulveda MA, Ruiz-Ribó MD.

Antimicrob Agents Chemother. 1995 Sep;39(9):2061-7.

38.

Semiclassical propagation: How long can it last?

Sepúlveda MA, Tomsovic S, Heller EJ.

Phys Rev Lett. 1992 Jul 20;69(3):402-405. No abstract available.

PMID:
10046930
39.

Confusional syndrome as the presenting form of calcium pyrophosphate dihydrate deposition disease.

Aragón A, Sepúlveda MA, Cerón A.

Br J Rheumatol. 1992 Feb;31(2):144. No abstract available.

PMID:
1737232
40.

Time domain approach to semiclassical dynamics: Breaking the log time barrier.

Heller EJ, Tomsovic S, Sepulveda MA.

Chaos. 1992 Jan;2(1):105-115.

PMID:
12779957
41.

[Liver abscess caused by non-typhi Salmonella in patients infected with HIV].

Sánchez L, Sepúlveda MA, Garrido E, Sánchez C.

Rev Clin Esp. 1991 Dec;189(9):447. Spanish. No abstract available.

PMID:
1792382
42.

[Microangiopathic hemolytic anemia associated with breast cancer].

Yuste R, Castañeda E, Sepúlveda MA, Tutor A.

Rev Clin Esp. 1990 Jan;186(1):45-6. Spanish. No abstract available.

PMID:
2320773
43.

Spectral analysis of conservative dynamical systems.

Sepúlveda MA, Badii R, Pollak E.

Phys Rev Lett. 1989 Sep 18;63(12):1226-1229. No abstract available.

PMID:
10040508
44.

[Gastrc cancer: An epidemiologic and dietary study in 100 patients and 100 controls (author's transl)].

Csendes A, Medina E, Gaete MC, Sepúlveda MA.

Rev Med Chil. 1976 Oct;104(10):761-5. Spanish. No abstract available.

PMID:
1037335
45.

Tratamiento de la colelitiasis asintomática en una enferma de úlcera péptica.

SEPULVEDA MAQUEO, et al.

Prensa Med Mex. 1949 Feb;14(2):44-6. Undetermined Language. No abstract available.

PMID:
18118066

Supplemental Content

Loading ...
Support Center